GSK was using monophosphoryl lipid A (MPL) to boos
Post# of 145529
Quote:
Percent of total immune cells in long-term Leronlimab treatment in humans.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970399/
Quite awhile back I posited that leronlimab may be able to boost vaccine efficacy. It may have been in relation to Covid-19 vaccines. There may be another avenue to what GSK's MPL can do if anybody would pay attention.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)